9th Annual Biomarkers Congress

Drug Design: Novartis Pharmaceuticals

Total Score People Score Events Score
106 82 76
Date Event Presentation Speakers
December 4, 2012 4th World Epigenetics Summit Epigenetics - Impact for Translational and Drug Safety Sciences Remi Terranova
November 3, 2010 DIA’s 8th Annual Canadian Meeting: “Keeping Canada on the Map: Fostering Innovation and Access to Drugs in Canadaâ€� TRACK 1 – Clinical Development - Innovations in Clinical Development Diane Colizza
TRACKS 2 and 3 – Reimbursement/Regulatory - Common Drug Review Pre-NOC Alain Boisvert
Adaptive Clinical Trial Designs: Where Is Industry with Respect to Adaptive Design? Jeffrey Maca
August 25, 2010 Co-Development of Drugs and Diagnostics Lumiracoxib - Seeking a New Path Forward Through Use of a Companion Diagnostic Kevin Carl
May 19, 2010 Towards Personalized Cancer Medicine The Discovery and Application of Cancer Therapeutics in the Genomic Era William R Sellers
PANEL DISCUSSION William R Sellers
November 2, 2009 Track 4: Fourth Annual GPCR-based drug discovery Targeting GPCR Activity: Conventional and Novel Label-free cAMP Assays Sandra Siehler, Ph.D., Research Investigator II, Novartis Institute for BioMedical Research Sandra Siehler
November 2, 2009 Track 3: Fourth Annual Ion Channels as Therapeutic Targets Evaluation of Available Technologies for Ligand-gated Ion Channel Safety Profiling and Screening Gul Erdemli
September 24, 2009 Track 2: Implementing Personalized Medicine : Inaugural Targeted Therapy Biomarkers - Driven Drug and Diagnostic Co-Development in Oncology: Current Trends and Future Approaches Miro Venturi
August 24, 2009 Specialized Protein Expression Systems Baculovirus Generated Proteins for Structure-Based Drug Design: Lessons Learned James Groarke
Exploring the Myth of Glycosylation for Crystallization Paul Ramage
August 17, 2009 Fourth Annual Novel Vaccines: Design & Development Structure-Based Rational Design of HIV Env Immunogens for Vaccine Development Indresh K. Srivastava
August 5, 2009 Drug Safety Strategies to De-Risk Compounds in silico Methods in Drug Safety Josef Scheiber
July 1, 2009 Advances in Oral Dose Manufacturing Assessing the Effects of API Particle Size Jeewan Thakur
Applying Solid Dispersion and Nanoparticulate Manufacturing Technologies for Enhanced Drug Delivery Carsten Timpe
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety KEYNOTE PANEL DISCUSSION Laszlo Urban
June 9, 2009 Inaugural The Expanding Impact of New Animal Models in Drug Safety Early Prediction of Clinical Adverse Drug Reactions: in vitro Safety Pharmacology Laszlo Urban
June 8, 2009 RNAi for Functional Screens Development of a Flexible RNAi Screening Platform for Drug Discovery Anthony Orth
Chairperson’s Remarks Anthony Orth
June 4, 2009 Structure-Based Drug Design Main Conference Indresh K. Srivastava
June 1, 2009 Combination Products Best Practices for Performing Risk Assessment: How are small and large companies doing this? Gangadhar Sunkara
Chairperson’s Opening Remarks Gangadhar Sunkara
May 19, 2009 Amorphous Materials Evaluation of the Performance of Amorphous Dispersion Dieter Becker,
May 12, 2009 BioAvailability and BioEquivalence Statistical Issues in Biosimilarity Sandro Gsteiger
April 22, 2009 PI 3-Kinase Signaling in Disease (Z3) Keynote Address William R Sellers
April 7, 2009 Kinase Inhibitor Chemistry - Charting the Chemical Space Iterative Kinase Medium-Throughput Screening with 2D profile-QSAR and 3D AutoShim Models Eric Martin
April 6, 2009 Fourth Annual FRAGMENT-BASED DRUG DISCOVERY Virtual Fragment Linking: An Approach to Identify Potent Binders from Low Affi nity Fragment Hits Meir Glick
March 17, 2009 Bio Medical Asia 2009 Concept for integration of QbD for enhanced efficiency in biologics process development Christian H. Leist
March 16, 2009 High Throughput Screening for Biological Systems IN VITRO SCREENING FOR METABOLIC STABILITY TO PROVIDE CHEMISTRY ALTERNATIVES Alfred Zimmerlin
MODULATION OF mRNA STABILITY AS A DRUG DISCOVERY PLATFORM Christian Parker
February 24, 2009 Pharmaceutical Analysis Course Overview of the regulatory directives governing the commercial area Andreas Trute
February 23, 2009 Advances and Progress in Drug Design VIII KEY ASPECTS FOR THE DESIGN OF A COMPREHENSIVE DRUG DISCOVERY SCREENING COLLECTION Edgar Jacoby
February 17, 2009 Pharma/Biotech Patent Litigation Chair’s Opening Remarks Peter de Weerd
Ensuring that Strategic Litigation Decisions are Aligned with International Business Goals Peter de Weerd
February 9, 2009 Immunogenicity for Biologics 2009 Parallel analysis of exposure and immunogenicity by Biacore in pre-clinical studies Annette Zaar
February 8, 2009 CHEMISTRY IN CANCER RESEARCH: A Vital Partnership in Cancer Drug Discovery and Development Session 3: Chemistry in Support of Lead Discovery/Screening, Hit Validation, and Natural Products Jeremy S. Caldwell
Session 6: Chemistry in Support of Cancer Drug Discovery/Case Histories II Jean Cuiné,
January 26, 2009 Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks J Carl Barrett
January 26, 2009 Biomarker Assay Development Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks J Carl Barrett
Opportunities and Challenges of Biomarker Assays in Drug Development Francois Legay
Target-Related Pharmacodynamic Analysis to Guide Successful Development of Biological Therapies: Novel Biomarker Concepts and Analytical Strategies Miro Venturi
January 26, 2009 Translational Cancer Medicine Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks J Carl Barrett
TRANSLATIONAL IMAGING : Translational Molecular Imaging: Oncology Syed Mahmood
January 26, 2009 7th Annual Partnering with Central Labs B2 : The Use of Imaging Biomarkers in Phase I/II trials Haren Rupani
Technical Hot Topics Haren Rupani
Track A : Improve Patient Care, Transparency and Process Efficiency in Global Studies Scott Sawicki
Track A : Central Lab Cost Drivers and Logistics Discussion Forum Scott Sawicki
January 5, 2009 High Content Analysis High-Content Screen to Look for Inhibitors of Virus Entry Marjo Simonen
Evaluation of Data Analysis Tools for the Multivariate Classification of Compound Responses Detected by High-Content Screening Anne Kuemmel
December 9, 2008 3rd Annual Congress Strategies to enhance Solubility and Drug Absorption Drug solubilisation strategies: Applying solid dispersion and nanoparticulate formulation approaches in drug development Carsten Timpe,
Lipid-based drug delivery systems to enhance solubility and absorption of poorly water-soluble drugs Jean Cuiné,
From animal-to-man: Pharmacokinetics and scalability to humans - a formulators’ perspective Dieter Becker,
December 2, 2008 2nd Annual:Outsourcing Preclinical Development Outsourcing DMPK studies Miro Venturi,
December 2, 2008 2nd Annual: Pre-clinical and clinical safety testing for new drugs Improving translation to clinical trials through the use of human hepatocytes in culture Armin Wolf,
What could be introduced into the pre-clinical toolkit to more accurately predict TdP risk. Is this necessary? Bérengère Dumotier
December 2, 2008 4th Annual Global Imaging Summit -The Application of Molecular and Cellular Imaging in Drug Discovery & Optimising Imaging Techniques in Preclinical and Clinical Drug Development 1: The use of in vivo models in drug discovery imaging Thomas Krucker,
2 : Panel Debate: How translatable is preclinical and clinical imaging? Raymond Josephsson,
2 : The importance of translatability in imaging and how this can improve preclinical and clinical trials Raymond Josephsson,
2 : Exploratory imaging in oncology clinical trials - Where are we today? Haren Rupani
December 2, 2008 2nd Annual Lead Discovery Summit 2008:-Compound Library Design, Synthesis & Acquisition Type 2 and type 3 kinase targeting compound libraries Doriano Fabbro,
Decision criteria in cherry picking compounds from large collections for screening campaigns: What have been the most successful methods? Ansgar Schuffenhauer,
December 2, 2008 The 8th World Drug Discovery & Development Summit 2008 PREDICTING DRUG PROMISCUITY Jacques Hamon
November 26, 2008 4th Annual Audits and Inspections for Clinical Trials and Pharmacovigilance Maximising the value of CRO relationships in developing audits together Elisabetta di Martino,
November 25, 2008 6th Annual Stability Testing for Pharmaceuticals Management of OOS and OOT results Joseph Kottathu
November 17, 2008 Mastering Process Chemistry Large-Scale Synthesis of Discodermolide, a Marine Natural Product for the Treatment of Advanced Solid Tumors Frederick Kinder
November 17, 2008 BIO-Europe 2008 What Buyers Want: Understanding What Big Pharma Expect to See in Out-Licensing Documents Axel Maibuecher
November 12, 2008 Third Annual Post-Approval Drug Safety Strategies: Best Practices to Mitigate Risks throughout the Product's Life Cycle Chairperson’s Remarks John Ferguson
Plotting a Strategy for the Best Benefit-Risk Ratio John Ferguson
November 12, 2008 11th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements Successfully Negotiating Collaborative Research Agreements with Academic Institutions Stephanie Oestreich
November 11, 2008 Stability Testing for Biologics Characterisation of degradation products of antibodies using HPLC and mass spectrometry Hui Zhao
November 4, 2008 Bioanalytical Autumn School Comparability - choosing the correct analytical tools Claudia Magagnoli
October 20, 2008 Protein Expression Europe The Benefits of Fusion Tags for an Improved Protein Production with E. coli and BEVS Lukas Leder
Baculovirus and E.coli- Generated Proteins for Structure-Based Drug Design – Lessons Learned James M Groarke
October 14, 2008 Crystal Form Selection and Crystallisation of API Opening remarks from the Chairperson Peter Karpinski
Closing remarks from the Chairperson Peter Karpinski
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics The TeGenero Story: What Happened at Northwick Park and Lessons Learned Jenny Sims
September 29, 2008 Genomic Biomarkers Biomarker Application in Oncology Clinical Development Michael Shi
September 17, 2008 BACULOVIRUS TECHNOLOGY Multi-Parallel Protein Production: Overcoming the Challenges to Accelerate Structural Based Drug Design Ian Hunt
June 19, 2008 Virtual Discovery Europe Integration of Image-Based Cytological Phenotypes with Computational Ligand-Target Prediction to Identify Mechanisms of Action Andreas Bender
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Harmonization of International Standards for Oncology Products Daniel Lapadula
Panel Discussion Daniel Lapadula
May 18, 2008 G Protein-Coupled Receptors: New Insights in Functional Regulation and Clinical Application (E2) Deorphanized GPCRs Deborah Nguyen
May 4, 2008 Impact China IV: Pharmaceutical R&D Global Summit Keynote Address: Chinese SFDA and Global Drug Development - Quality, Science and Speed Paul Dai
March 31, 2008 Pharmaceutical Sales & Marketing Executive Congress: Generating BIG Returns in a Changing Compliance Environment The ‘State of the Industry’ – Challenges & Opportunities in 2008 and Beyond Lori Ryan
March 31, 2008 China 2008 Pharmaceutical R&D Summit Leveraging Traditional Chinese Medical Knowledge for Modern Medicine: Collaborating with the Shanghai Institute of Materia Medica Paul Herrling
Global Pharma Exchange Roundtable En Li
Track II Clinical Research Development in China – Experiences, Improvements and Changes Chairperson’s Opening Remarks Paul Dai
March 25, 2008 Preclinical Development Mechanistic Cardiac Modeling: Concepts and Utility in Drug Development Anna Georgieva
Predictive Value of in Vitro Safety Studies Willi Suter
Imaging in Phase II/III Clinical Development Haren Rupani
March 25, 2008 TRANSLATIONAL MEDICINE Imaging in Phase II/III Clinical Development Haren Rupani
March 25, 2008 TRENDS IN DRUG SAFETY Mechanistic Cardiac Modeling: Concepts and Utility in Drug Development Anna Georgieva
Predictive Value of in Vitro Safety Studies Willi Suter
March 19, 2008 The Healthcare Dealmaking Symposium Licensing Deals Jeremy M. Levin
February 19, 2008 Screening Europe Track A Modern Approaches for an Old Problem: High-Throughput Screening and Compound Profiling of Proteases Lorenz Mayr
Track B Emerging GPCR Assay Technologies for Drug Discovery Sandra Siehler
February 18, 2008 Fragment-based Lead Discovery Conference Successes and Surprises with Fragments Wolfgang Jahnke
Morning Session: Methods & Emerging Technologies, Part I Wolfgang Jahnke
In vivo Incorporation of NMR-active Unnatural Amino Acids Bernhard Geierstanger
December 4, 2007 7th World Drug Discovery & Development Summit 2007 Conference room 2 OPTIMISING TECHNOLOGIES TO INCREASE SPEED TO CLINIC AND SPEED TO MARKET Hans-Peter Knopf
December 1, 2007 47TH American Socieity of Cell Biology Solving Cell Culture Problems: Lori Ryan
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) CONTRIBUTION OF ACADEMIC INSTITUTES (13:30-15:00) Gangadhar Sunkara
CONTRIBUTION OF ACADEMIC INSTITUTES: Pharmaceutical Research and Development Environment in India: The Contribution of Aca-demic Institutes (13:30-14:00) Gangadhar Sunkara
PRECLINICAL DEVELOPMENT AND CHALLENGES (15:30-18:45) Gangadhar Sunkara
PRECLINICAL DEVELOPMENT AND CHALLENGES: INTERACTIVE PANEL :Partnership and Outsourcing Deals in India – Successes and Failures (17:00-17:45) Gangadhar Sunkara
November 5, 2007 Bio-Pharma Alliance Summit Nov (05-06) The Novartis / Human Genome Sciences Albuferon Alliance – Key Success Factors in Driving Successful Biotech/Big Pharma Alliances (14:35-15:15) Mark Coflin
October 17, 2007 Second Annual Ion Channels: An Emerging Target for Therapeutic Development Oct (17-18) CRAC – AN EMERGING TARGET (08:35-09:40) Martin Gosling
CRAC – AN EMERGING TARGET: Chairperson’s Remarks (08:35-08:40) Martin Gosling
TECHNOLOGIES FOR ION CHANNEL DRUG DISCOVERY: Screening Ion Channel Targets with Therapeutic Potential in Respiratory Disease: Application of Automated Electrophysiology (09:40-12:25) Martin Gosling
TECHNOLOGIES FOR ION CHANNEL DRUG DISCOVERY (09:40-12:25) Martin Gosling
October 16, 2007 Second Annual Putting Theory into Practice: Adaptive Clinical Trial Designs (Oct 16-17 SESSION I: LAYING THE GROUND WORK FOR EARLY DECISION MAKING (13:45 - 19:00) Jose Pinheiro
SESSION I: Evaluating Adaptive Dose-Ranging Studies: Conclusions and Recommendations from the PhRMA Working Group (16:00 - 16:30) Jose Pinheiro
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) Keynote Presentation (08:45-09:30) J Carl Barrett
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Drug Repositioning Summit) (12:30-17:15) Jeremy S. Caldwell, Laszlo Urban
SCREENING AGAINST MULTIPLE TARGETS: Integrative In Vitro Safety Pharmacology Profiling to Predict Clinical Adverse Effects (15:45-16:15) Laszlo Urban
SCREENING AGAINST MULTIPLE TARGETS: Automated Robotic Molecular Profiling in Cells for New Therapeutic Directions (14:15-14:45) Jeremy S. Caldwell
SELECTING LEADS AND DETECTING ADVERSE ACTIVITY (14:00-17:30) Andreas Bender
SELECTING LEADS AND DETECTING ADVERSE ACTIVITY: Compound Profiling by Predicting On-Target Activities, Compound Promiscuity and Adverse Drug Reactions (16:00-16:30) Andreas Bender
October 10, 2007 Drug Repositioning Summit: Finding New routes to success (Oct 10-11) SCREENING AGAINST MULTIPLE TARGETS: Automated Robotic Molecular Profiling in Cells for New Therapeutic Directions (14:15-14:45) Jeremy S. Caldwell
SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Compound Profiling) (13:30-17:15) Jeremy S. Caldwell, Laszlo Urban
SCREENING AGAINST MULTIPLE TARGETS: Broad-Scale In Vitro Pharmacology Profiling to Predict Clinical Adverse Effects and for ADME Profiling (15:45-16:15) Laszlo Urban
October 2, 2007 IVT 's Lab Week Requirements Definition | Session 8 Susan Cleary, Parsa Famili
Writing Requirements Keeping Validation in Mind | Session 8 Susan Cleary, Parsa Famili
Finalizing the System | Session 8 Susan Cleary, Parsa Famili
Interactive Exercise | Session 8 Susan Cleary, Parsa Famili
September 27, 2007 Protein Expression Europe (Sep 27-28) Drug Discovery Applications (13:00-15:15) Lorenz Mayr
Drug Discovery Applications: Miniaturization and Automation of Protein Expression for High-Throughput Screening and Structural Biology (13:15-13:45) Lorenz Mayr
September 19, 2007 Baculovirus Technology (Sep 19-20) Protein Production (13:45-16:00) Ian Hunt
Protein Production: Baculovirus Mediated Protein Production - Overcoming the Challenges to Accelerate Drug Discovery (13:50-14:25) Ian Hunt
Protein Expression: A Fast and Multi-Parallel Approach for Small-Scale Expression Screening Using the BEVS System (16:30-17:00) Aline Tirat-Boeuf
Protein Expression (16:00-19:00) Aline Tirat-Boeuf
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.